276 related articles for article (PubMed ID: 24642777)
41. IP
Xu H; Guan N; Ren YL; Wei QJ; Tao YH; Yang GS; Liu XY; Bu DF; Zhang Y; Zhu SN
BMC Nephrol; 2018 Jun; 19(1):140. PubMed ID: 29907098
[TBL] [Abstract][Full Text] [Related]
42. Role of Epac and protein kinase A in thyrotropin-induced gene expression in primary thyrocytes.
van Staveren WC; Beeckman S; Tomás G; Dom G; Hébrant A; Delys L; Vliem MJ; Trésallet C; Andry G; Franc B; Libert F; Dumont JE; Maenhaut C
Exp Cell Res; 2012 Mar; 318(5):444-52. PubMed ID: 22240166
[TBL] [Abstract][Full Text] [Related]
43. Oncogenic K-ras expression is associated with derangement of the cAMP/PKA pathway and forskolin-reversible alterations of mitochondrial dynamics and respiration.
Palorini R; De Rasmo D; Gaviraghi M; Sala Danna L; Signorile A; Cirulli C; Chiaradonna F; Alberghina L; Papa S
Oncogene; 2013 Jan; 32(3):352-62. PubMed ID: 22410778
[TBL] [Abstract][Full Text] [Related]
44. Differential signaling of cyclic AMP: opposing effects of exchange protein directly activated by cyclic AMP and cAMP-dependent protein kinase on protein kinase B activation.
Mei FC; Qiao J; Tsygankova OM; Meinkoth JL; Quilliam LA; Cheng X
J Biol Chem; 2002 Mar; 277(13):11497-504. PubMed ID: 11801596
[TBL] [Abstract][Full Text] [Related]
45. Increased expression of olfactomedin-1 and myocilin in podocytes during puromycin aminonucleoside nephrosis.
Bohr DC; Koch M; Kritzenberger M; Fuchshofer R; Tamm ER
Nephrol Dial Transplant; 2011 Jan; 26(1):83-92. PubMed ID: 20595200
[TBL] [Abstract][Full Text] [Related]
46. Dysfunction of the PGC-1α-mitochondria axis confers adriamycin-induced podocyte injury.
Zhu C; Xuan X; Che R; Ding G; Zhao M; Bai M; Jia Z; Huang S; Zhang A
Am J Physiol Renal Physiol; 2014 Jun; 306(12):F1410-7. PubMed ID: 24808537
[TBL] [Abstract][Full Text] [Related]
47. Leptin potentiates antiproliferative action of cAMP elevation via protein kinase A down-regulation in breast cancer cells.
Naviglio S; Di Gesto D; Illiano F; Chiosi E; Giordano A; Illiano G; Spina A
J Cell Physiol; 2010 Nov; 225(3):801-9. PubMed ID: 20589829
[TBL] [Abstract][Full Text] [Related]
48. PGE(2) induces COX-2 expression in podocytes via the EP(4) receptor through a PKA-independent mechanism.
Faour WH; Gomi K; Kennedy CR
Cell Signal; 2008 Nov; 20(11):2156-64. PubMed ID: 18762248
[TBL] [Abstract][Full Text] [Related]
49. Fluvastatin ameliorates podocyte injury in proteinuric rats via modulation of excessive Rho signaling.
Shibata S; Nagase M; Fujita T
J Am Soc Nephrol; 2006 Mar; 17(3):754-64. PubMed ID: 16452496
[TBL] [Abstract][Full Text] [Related]
50. Hepatocyte growth factor signaling ameliorates podocyte injury and proteinuria.
Dai C; Saleem MA; Holzman LB; Mathieson P; Liu Y
Kidney Int; 2010 Jun; 77(11):962-73. PubMed ID: 20375988
[TBL] [Abstract][Full Text] [Related]
51. Mitochondrial division inhibitor 1 reduces dynamin-related protein 1 and mitochondrial fission activity.
Manczak M; Kandimalla R; Yin X; Reddy PH
Hum Mol Genet; 2019 Jan; 28(2):177-199. PubMed ID: 30239719
[TBL] [Abstract][Full Text] [Related]
52. The activation of extracellular signal-regulated kinase is responsible for podocyte injury.
Liu S; Ding J; Fan Q; Zhang H
Mol Biol Rep; 2010 Jun; 37(5):2477-84. PubMed ID: 19728154
[TBL] [Abstract][Full Text] [Related]
53. Trehalose, an mTOR independent autophagy inducer, alleviates human podocyte injury after puromycin aminonucleoside treatment.
Kang YL; Saleem MA; Chan KW; Yung BY; Law HK
PLoS One; 2014; 9(11):e113520. PubMed ID: 25412249
[TBL] [Abstract][Full Text] [Related]
54. Tripterygium glycoside protects against puromycin amino nucleoside‑induced podocyte injury by upregulating autophagy.
Gong J; Jin J; Zhao L; Li Y; Li Y; He Q
Int J Mol Med; 2018 Jul; 42(1):115-122. PubMed ID: 29620171
[TBL] [Abstract][Full Text] [Related]
55. Antioxidative Stress Effects of Salvia przewalskii Extract in Experimentally Injured Podocytes.
Liu X; Liu Y; Yang Y; Xu J; Dai D; Yan C; Li X; Tang R; Yu C; Ren H
Nephron; 2016; 134(4):253-271. PubMed ID: 27529846
[TBL] [Abstract][Full Text] [Related]
56. Mitochondrially localized PKA reverses mitochondrial pathology and dysfunction in a cellular model of Parkinson's disease.
Dagda RK; Gusdon AM; Pien I; Strack S; Green S; Li C; Van Houten B; Cherra SJ; Chu CT
Cell Death Differ; 2011 Dec; 18(12):1914-23. PubMed ID: 21637291
[TBL] [Abstract][Full Text] [Related]
57. Extracellular ATP modulates podocyte function through P2Y purinergic receptors and pleiotropic effects on AMPK and cAMP/PKA signaling pathways.
Szrejder M; Rachubik P; Rogacka D; Audzeyenka I; Rychłowski M; Angielski S; Piwkowska A
Arch Biochem Biophys; 2020 Nov; 695():108649. PubMed ID: 33122160
[TBL] [Abstract][Full Text] [Related]
58. Rac1 in podocytes promotes glomerular repair and limits the formation of sclerosis.
Asao R; Seki T; Takagi M; Yamada H; Kodama F; Hosoe-Nagai Y; Tanaka E; Trejo JAO; Yamamoto-Nonaka K; Sasaki Y; Hidaka T; Ueno T; Yanagita M; Suzuki Y; Tomino Y; Asanuma K
Sci Rep; 2018 Mar; 8(1):5061. PubMed ID: 29567961
[TBL] [Abstract][Full Text] [Related]
59. 5'-AMP-activated protein kinase attenuates adriamycin-induced oxidative podocyte injury through thioredoxin-mediated suppression of the apoptosis signal-regulating kinase 1-P38 signaling pathway.
Gao K; Chi Y; Sun W; Takeda M; Yao J
Mol Pharmacol; 2014 Mar; 85(3):460-71. PubMed ID: 24378334
[TBL] [Abstract][Full Text] [Related]
60. Shaping mitochondrial dynamics: The role of cAMP signalling.
Di Benedetto G; Gerbino A; Lefkimmiatis K
Biochem Biophys Res Commun; 2018 May; 500(1):65-74. PubMed ID: 28501614
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
